The Integrated and Continuous Biomanufacturing (ICB) Conference is ECI’s premiere international conference in continuous and integrated biomanufacturing. As global competitive pressures continue to force companies to innovate to succeed, integrated continuous processing creates opportunities to accelerate process development and reduce manufacturing costs while enhancing flexibility and product quality. Ultimately, these collective improvements in efficiency and quality will help us better achieve our primary objective in the field – to increase patient access to transformative therapies.

Impressive technological advances have been made over the past decade to enable the implementation of continuous bioprocessing. ICB VI aims to build on the strong momentum generated in previous conferences of this series by developing an exciting and engaging program showcasing progress in implementation of integrated continuous biomanufacturing technologies for GMP biomanufacturing via case studies of clinical and commercial bioprocesses. ICB VI will highlight progress across the ICB discipline, including areas related to Regulatory Affairs, Simplification, Emerging Therapeutic Modalities, Process Analytical Technology (PAT), Sustainability, as well as Modeling, Automation, and Control.

ICB VI will bring together leading scientists and engineers from academia, industry and regulatory who are actively engaged in creating and enabling integrated continuous biomanufacturing. We look forward to welcoming invitees to Leesburg, Virginia, USA to reflect on the field’s progress and to harness our collective capabilities to drive towards a more efficient and sustainable future.

Event link here.